XML 93 R79.htm IDEA: XBRL DOCUMENT v3.25.3
Note 17 - Related Parties (Details Textual) - USD ($)
1 Months Ended 9 Months Ended
Jun. 02, 2025
Jan. 29, 2025
Jan. 06, 2025
Oct. 28, 2024
Oct. 25, 2024
Sep. 03, 2024
May 01, 2024
Jan. 09, 2023
Apr. 30, 2025
Sep. 30, 2025
Jul. 11, 2025
Jun. 20, 2025
Feb. 28, 2025
Aug. 23, 2024
Aug. 22, 2024
Jul. 25, 2024
May 30, 2024
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures in Period (in shares) 13,154                                
Class of Warrant or Right, Exercised in Period (in shares)                   162,947              
Cardionomix Inc. [Member]                                  
Subsidiary, Ownership Percentage, Parent                   82.00%     82.00%        
KardioNav, Inc. [Member]                                  
Subsidiary, Ownership Percentage, Parent                   57.00%   57.00%          
KardioNav, Inc. [Member] | Chelak iECG, Inc. [Member]                                  
Subsidiary, Ownership Percentage, Parent                       33.00%          
Series H Warrants [Member]                                  
Class of Warrant or Right, Exercised in Period (in shares)         104,737                        
Series I Warrants [Member]                                  
Class of Warrant or Right, Exercised in Period (in shares)         122,368                        
KardioNav Notes [Member]                                  
Debt Instrument, Interest Rate, Stated Percentage                       4.20%          
Debt Instrument, Face Amount                       $ 150,000          
Non-plan Options [Member]                                  
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross (in shares)                   26,315              
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures in Period (in shares) 1,315                                
Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Grants in Period, Weighted Average Exercise Price (in dollars per share)                   $ 10.07              
Share-Based Payment Arrangement, Option [Member]                                  
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross (in shares)                   160,360              
Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Grants in Period, Weighted Average Exercise Price (in dollars per share)                   $ 6.34              
Chief Commercial Officer [Member] | Non-plan Options [Member]                                  
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross (in shares)   13,154         1,315                    
Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Grants in Period, Weighted Average Exercise Price (in dollars per share)   $ 7.98         $ 101.1                    
Chief Commercial Officer [Member] | Share-Based Payment Arrangement, Tranche Two [Member] | Non-plan Options [Member]                                  
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross (in shares)   1,315                              
Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Period (Year)   4 years                              
Chief Commercial Officer [Member] | Share-Based Payment Arrangement, Tranche One [Member] | Non-plan Options [Member]                                  
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross (in shares)   1,315                              
Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Rights, Percentage             20.00%                    
Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Period (Year)             5 years                    
Chief Commercial Officer [Member] | Share-Based Payment Arrangement, Tranche Three [Member] | Non-plan Options [Member]                                  
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross (in shares)   1,644                              
Chief Financial Officer [Member]                                  
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross (in shares)     26,315                            
Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Grants in Period, Weighted Average Exercise Price (in dollars per share)     $ 10.07                            
Chief Financial Officer [Member] | Non-plan Options [Member]                                  
Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Grants in Period, Weighted Average Exercise Price (in dollars per share)     $ 10.07                            
Chief Financial Officer [Member] | Share-Based Payment Arrangement, Option [Member]                                  
Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Period (Year)     36 months                            
Chief Financial Officer [Member] | Share-Based Payment Arrangement, Tranche One [Member] | Non-plan Options [Member]                                  
Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Period (Year)     3 years                            
Old Catheter [Member] | Mr. Jenkins and Affiliates [Member]                                  
Business Acquisition, Equity Interest Issued or Issuable, Number of Shares (in shares)                   1,325.838              
Old Catheter [Member] | Mr. Jenkins Adult Children [Member]                                  
Business Acquisition, Equity Interest Issued or Issuable, Number of Shares (in shares)                   1,284.344              
Business Combination, Consideration Transferred, Equity Interest, Share Held, Number of Shares (in shares)                   9,239.285              
David Jenkins [Member]                                  
Convertible Notes Payable               $ 25,100,000                  
Interest Accrued and Unpaid, Forgiven Amount               $ 13,900,000                  
David Jenkins [Member] | LockeT Royalty [Member]                                  
Royalty Percentage               12.00%                  
David Jenkins [Member] | Conversion of Convertible Promissory Notes into Series X Preferred Stock [Member]                                  
Convertible Preferred Stock, Shares Issued upon Conversion (in shares)               7,856.251                  
Auston Locke [Member] | LockeT Royalty [Member]                                  
Royalty Percentage               5.00%                  
Royalty Guarantees, Commitments, Amount               $ 1,000,000 $ 1,000,000                
Auston Locke [Member] | LockeT Royalty [Member] | Royalty Payment After U.S. Patent Granted and One Million Paid [Member]                                  
Royalty Percentage                 5.00%                
Royalty Guarantees, Commitments, Amount                 $ 10,000,000                
Increase in Royalty Percentage                 2.00%                
Non-Executive Chief Operating Officer [Member]                                  
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross (in shares)                   757              
Non-Executive Chief Operating Officer [Member] | Share-Based Payment Arrangement, Tranche Two [Member]                                  
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures in Period (in shares)                   17              
Non-Executive Chief Operating Officer [Member] | Share-Based Payment Arrangement, Tranche One [Member]                                  
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross (in shares)                   740              
Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Grants in Period, Weighted Average Exercise Price (in dollars per share)                   $ 383.8              
Related Party [Member] | Related Party Notes [Member]                                  
Debt Instrument, Interest Rate, Stated Percentage                     4.20%     12.00% 8.00%    
Debt Instrument, Face Amount                     $ 150,000            
Jenkins Family Charitable Institute [Member]                                  
Debt Instrument, Face Amount                   $ 500,000              
Proceeds from Issuance Initial Public Offering           $ 500,000                      
Stock Issued During Period, Shares, New Issues (in shares)           13,947                      
Jenkins Family Charitable Institute [Member] | Prefunded Warrants [Member]                                  
Class of Warrant or Right, Number of Securities Called by Warrants or Rights (in shares)           12,368                      
Class of Warrant or Right, Exercise Price of Warrants or Rights (in dollars per share)           $ 0.0019                      
Class of Warrant or Right, Exercised in Period (in shares)       12,368                          
Stock Issued During Period, Shares, Warrant Exercises (in shares)       12,368                          
Jenkins Family Charitable Institute [Member] | Series H Warrants [Member]                                  
Class of Warrant or Right, Number of Securities Called by Warrants or Rights (in shares)           26,316                      
Class of Warrant or Right, Exercise Price of Warrants or Rights (in dollars per share)           $ 19                      
Jenkins Family Charitable Institute [Member] | Series I Warrants [Member]                                  
Class of Warrant or Right, Number of Securities Called by Warrants or Rights (in shares)           26,316                      
Class of Warrant or Right, Exercise Price of Warrants or Rights (in dollars per share)           $ 19                      
Jenkins Family Charitable Institute [Member] | Series J Warrants [Member]                                  
Class of Warrant or Right, Number of Securities Called by Warrants or Rights (in shares)           26,316                      
Class of Warrant or Right, Exercise Price of Warrants or Rights (in dollars per share)           $ 19                      
Class of Warrant or Right, Distributed (in shares)       23,684                          
Jenkins Family Charitable Institute [Member] | Related Party Notes [Member]                                  
Debt Instrument, Face Amount                               $ 500,000  
Mr. Jenkins [Member]                                  
Debt Instrument, Face Amount                   $ 500,000              
Mr. Jenkins [Member] | Cardionomix Inc. [Member]                                  
Subsidiary, Ownership Percentage, Parent                       3.00% 5.00%        
Mr. Jenkins [Member] | Related Party Notes [Member]                                  
Debt Instrument, Face Amount                                 $ 500,000
Mr. Jenkins and Affiliates [Member] | Cardionomix Inc. [Member]                                  
Subsidiary, Ownership Percentage, Parent                       7.00% 7.00%        
Certain Third Parties [Member] | Cardionomix Inc. [Member]                                  
Subsidiary, Ownership Percentage, Parent                         6.00%